ATXI
Avenue Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−4.48%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+61.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 6, 2026 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 111,209 | $0.00 |
| Apr 2, 2025 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 33,724 | $0.00 |
| Dec 3, 2024 | Herskowitz Neil · director | Sale | 23 | $2.00 |
| Nov 7, 2024 | KRANZLER JAY D · director | Sale | 61 | $2.24 |
| Oct 1, 2024 | KRANZLER JAY D · director | Purchase | 497 | $2.50 |
| Oct 1, 2024 | KRANZLER JAY D · director | Purchase | 3 | $2.40 |
| Sep 25, 2024 | ROSENWALD LINDSAY A MD · director | A-Award | 30,000 | $2.46 |
| Sep 25, 2024 | Herskowitz Neil · director | A-Award | 30,000 | $2.46 |
| Sep 25, 2024 | Oltmans Curtis Gale · director | A-Award | 30,000 | $2.46 |
| Sep 25, 2024 | MacLean Alexandra · director, officer: Chief Executive Officer | A-Award | 170,000 | $0.00 |
| Sep 25, 2024 | KRANZLER JAY D · director | A-Award | 30,000 | $2.46 |
| Sep 25, 2024 | Jin David · officer: Interim PFO and COO | A-Award | 65,000 | $0.00 |
| Sep 25, 2024 | Charles Faith L. · director | A-Award | 30,000 | $2.46 |
| Apr 17, 2024 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 413,507 | $0.00 |
| Jan 3, 2024 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 2,101,496 | $0.00 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 264,000 | $0.14 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 126,000 | $0.14 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 128,000 | $0.14 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 20,000 | $0.14 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 61,000 | $0.14 |
| Dec 13, 2023 | Davidow Robert L · 10 percent owner | Sale | 18,000 | $0.15 |
| Sep 12, 2023 | ROSENWALD LINDSAY A MD · director | Purchase | 348,675 | $0.72 |
| Sep 12, 2023 | Fortress Biotech, Inc. · 10 percent owner | Purchase | 418,410 | $0.72 |
| Jul 5, 2023 | Charles Faith L. · director | A-Award | 100,000 | $1.14 |
| Jul 5, 2023 | Jin David · officer: Interim PFO and COO | A-Award | 250,000 | $1.14 |
| Jul 5, 2023 | ROSENWALD LINDSAY A MD · director | A-Award | 100,000 | $1.14 |
| Jul 5, 2023 | KRANZLER JAY D · director | A-Award | 100,000 | $1.14 |
| Jul 5, 2023 | Oltmans Curtis Gale · director | A-Award | 100,000 | $1.14 |
| Jul 5, 2023 | Herskowitz Neil · director | A-Award | 100,000 | $1.14 |
| Jul 3, 2023 | MacLean Alexandra · director, officer: Chief Executive Officer | A-Award | 800,000 | $1.14 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 6, 2026